REQUEST A DEMO
Total
USD $0.00
Search more companies

Sudarshan Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sudarshan Pharmaceuticals Pvt Ltd Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sudarshan Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 23/08/1985. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP1985PTC002978 and registration number is 002978. The company is a manufacturing, trade company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, wholesale trading.

Legal Address
17-B/18A, Sector. F Industrial. Area, Sanwer, Road
Indore; Madhya Pradesh; Postal Code: 000000

Contact Details: Purchase the Sudarshan Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Sudarshan Pharmaceuticals Pvt Ltd report to view the information.
Outstanding Shares:
Purchase the Sudarshan Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Sudarshan Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
August 23, 1985
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Manager
Company Performance
Financial values in the chart are available after Sudarshan Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.38%
Total operating revenue
-1.39%
Operating profit (EBIT)
-3.66%
EBITDA
-6.9%
Net Profit (Loss) for the Period
-2.57%
Total assets
-11.1%
Total equity
46.62%
Operating Profit Margin (ROS)
-0.18%
Net Profit Margin
-0.07%
Return on Equity (ROE)
-11.25%
Debt to Equity Ratio
-93.61%
Quick Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?